In multivariable analysis, PODXL remained a significant prognostic factor only in I-type tumours (HR = 5.12, 95 % CI 1.43–18.31 for RFS, Table 2, and HR = 7.31, 95 % CI 2.12–25.16 for OS, Table 3). This evidence concerns the gene PODXL and neoplasm.